Stocks TelegraphStocks Telegraph
Stock Ideas

PRAX Stock Performance and Key Statistics

NASDAQ : PRAX

Praxis Precision Medicines

$303.92
5.605+1.88%
Open: 11:42 AM
72.23
BESG ScoreESG Rating

stock performance chart

PRAX Fundamental Analysis

Based on recent data, Praxis Precision Medicines, Inc. (PRAX) shows an Average True Range (ATR) of 19.21 and an Enterprise Value of 795.07M. Its average trading volume over the past 3 months is 487.99K, indicating liquidity. These fundamental metrics provide insight into PRAX's underlying financial health and market activity.

ATR19.21
Enterprise Value795.07M
Avg Vol (3 Months)487.99K
Avg Vol (10 Days)444.88K

PRAX Technical Analysis Indicators

Praxis Precision Medicines, Inc. (PRAX) technical indicators as of March 23, 2026: the SMA 20 is 4.97%, SMA 50 at 12.03%, and SMA 200 at 141.01%. The RSI 14 value is 62.5, suggesting its current momentum. These technical analysis signals help assess PRAX's price trends and potential future movements.

SMA 204.97%
SMA 5012.03%
SMA 200141.01%
RSI 1462.5

PRAX Stock Performance Overview

Praxis Precision Medicines, Inc. (PRAX) stock performance overview as of March 23, 2026: The 52-week high is $356 (currently -4.36% below), and the 52-week low is $26.7 (currently 1,175.17% above). Over the past year, PRAX's performance is 361.32%, compared to the S&P 500's 16.54% change.

52-Week High356
52-Week High Chg-4.36%
52-Week Low26.7
52-Week Low Chg+1,175.17%
S&P 500 52-Week Chg16.54%

Praxis Precision Medicines, Inc. (PRAX) Historical Stock Performance

According to market data, Praxis Precision Medicines, Inc. (PRAX) stock's recent performance metrics show that over the last month, PRAX is 21.9%, with a Year-to-Date (YTD) performance of 9.95%. Over the past year, the stock has seen a 361.32% change. These figures summarize PRAX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High313356356356356356
Low285285263.5240.1226.7266.93
Performance+17.53%+21.90%+70.58%+487.53%+361.32%+9.95%

Industry Analysis and Valuation

According to current financial data, PRAX stock's P/E (TTM) ratio is -22.14, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for PRAX, including P/S (N/A), P/B (7.65), and P/FCF (-25.28), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationPRAXSector MedianIndustry AvgS&P 500
P/E (TTM)-22.14-1.23-5.1632.59
P/S (TTM)N/A3.71464.925.98
P/B (TTM)7.65-11.895.834.56
P/FCF (TTM)-25.2870.68-188.8331.7

Frequently Asked Questions

How is PRAX price-to-earnings ratio currently?
PRAX has a current P/E ratio of -22.14
How are PRAX's price-to-sale and price-to-book ratios?
The PRAX stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 7.65.
Is Praxis Precision Medicines, Inc.'s price-to-cashflow ratio high or low?
PRAX's price-to-free-cashflow (P/FCF) ratio is -25.28, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for PRAX?
Based on PRAX's recent bid, its distance from 20 days simple moving average is 4.97%. It is 12.03% apart from 50 days simple moving average, and it is 141.01% apart from 200 days simple moving average.
What is the 52-week price range for PRAX?
The 52-week high for PRAX is $356.00 which is -4.36% away from the current price level whereas the distance of that from the 52-week low of $26.70 stands at 1,175.17%.
An overview of PRAX's stock performance: how did it fare?
The performance of PRAX stock was not encouraging with most of its significant price indicators in green. Praxis Precision Medicines, Inc.(NASDAQ: PRAX) shares have moved upward +0.27% or $0.81 in the latest trading session and have gained 9.95% year-to-date (YTD). The stock has gained nearly 361.32% over the past year. After moving 70.58% over the trailing 3-month period, the stock is 487.53% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 17.53% a week and 21.9% a month.
What is PRAX's 14-day relative strength index (RSI)?
The current 14-day RSI for PRAX stock is 62.5. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For PRAX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Praxis Precision Medicines, Inc. (PRAX) has a 14-day ATR of 19.21.
What is PRAX's current enterprise value?
After closing at $297.50 with 21.14M of its shares outstanding, the current enterprise value of PRAX is roughly 795.07M.
Over the past year, how has the stock price of PRAX changed?
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is up 361.32% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 16.54%. PRAX stock price is also up 9.95% on its value in year-to-date trading.
What is the average trading volume for PRAX shares?
The number outstanding shares of PRAX is 21.14M, and of these 93.92% shares are freely available for trading. On average, PRAX stock has traded 444.88K shares per day for the past 10 days. A total of 728K shares changed hands during the last trading session with the average session volume of 495.25K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph